microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.

Abstract:

:Formation of cancer stem cells (CSCs) and increased cells proliferation are involved in tumorigenesis, tumour recurrence and therapy resistance and microRNA is essential for the development of the biological traits of CSCs and the increased cells proliferation. Studying molecular mechanism of tumorigenesis, tumour recurrence and therapy resistance of lung cancer will help us to further understand the pathogenesis and progression of the disease and offer new targets for effective therapies. In the present study, we found that miR-520a-3p expression is downregulated in NSCLC (non-small cell lung cancer) and SCLC (small cell lung cancer). miR-520a-3p can inhibit proliferation and cancer stem cell phenotype in NSCLC and SCLC cells. Overexpressing miR-520a-3p can degrade HOXD8 mRNA in NSCLC cells, but its overexpression cannot suppress HOXD8 in SCLC cells. HOXD8 protein is upregulated in NSCLC tissues and its overexpression can promote proliferation, formation of cancer stem cells, migration and invasion in NSCLC cells. MET amplification plays a pivotal role in gefitinib resistance in lung cancer. We found that miR-520a-3p can downregulate MET protein expression and HOXD8 can upregulate MET protein expression. Thus, we concluded that microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in NSCLC cells and restoration of microRNA-520a-3p might be a therapeutic strategy to reverse gefitinib resistance.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Liu Y,Miao L,Ni R,Zhang H,Li L,Wang X,Li X,Wang J

doi

10.3892/or.2016.5149

subject

Has Abstract

pub_date

2016-12-01 00:00:00

pages

3529-3535

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

36

pub_type

杂志文章
  • Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.

    abstract::Lapatinib, an inhibitor of human epidermal growth factor receptor 2 (HER2) phosphorylation, has been reported to inhibit several types of tumors such as HER2-overexpressing breast cancer. However, the effect of lapatinib on the malignant phenotype of human osteosarcoma (OS) cells and the potential molecular mechanisms...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2825

    authors: Long XH,Zhang GM,Peng AF,Luo QF,Zhang L,Wen HC,Zhou RP,Gao S,Zhou Y,Liu ZL

    更新日期:2014-01-01 00:00:00

  • Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.

    abstract::Acute lymphoblastic leukemia (ALL) is a malignant hematological disease. Tanshinone IIA (Tan IIA) has antitumor activity in vitro and in vivo. The aim of the present study was to investigate the effects of Tan IIA in combination with imatinib (IM) on the proliferation, apoptosis, migration and invasion of acute T lymp...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7453

    authors: Teng Z,Xu S,Lei Q

    更新日期:2020-02-01 00:00:00

  • Overexpression of the LKB1 gene inhibits lung carcinoma cell proliferation partly through degradation of c-myc protein.

    abstract::LKB1 encodes a serine/threonine kinase generally inactivated in human lung cancers, which mediates cancer cell proliferation, migration and differentiation, but its biological function has not been completely elucidated. In this study, we demonstrated that LKB1 was associated with a substantial reduction of c-myc expr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000305

    authors: Liang X,Nan KJ,Li ZL,Xu QZ

    更新日期:2009-04-01 00:00:00

  • Diagnostic and therapeutic role of microRNAs in oral cancer (Review).

    abstract::Oral cancer is one of the leading types of cancer and remains the most common cause of cancer‑related mortality in Asia. The pathogenesis of oral cancer is complicated and, due to lack of accurate diagnostic methods and efficient treatment strategies, oral cancer is responsible for a large number of deaths. Therefore,...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7854

    authors: Wang J,Lv N,Lu X,Yuan R,Chen Z,Yu J

    更新日期:2021-01-01 00:00:00

  • Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.

    abstract::Tanshinone IIA is known to induce apoptosis in several types of cancer cells. However, little is known about its activity in chemoresistant cells. The aim of this study was to investigate the anticancer properties of tanshinone IIA in cisplatin-resistant human ovarian cancer COC1/DDP cells in vitro. We used a variety ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2010.1107

    authors: Jiao JW,Wen F

    更新日期:2011-03-01 00:00:00

  • Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.

    abstract::In this study, we demonstrate an important role of activation of the hypoxia-inducible factor-1 (HIF-1) pathway in endometrial carcinogenesis and tumor phenotype development of endometrial carcinoma, and suggest a unique role of the HIF-1-target gene, differentiated embryo chondrocyte 2 (DEC2), in carcinogenesis. Hypo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yunokawa M,Tanimoto K,Nakamura H,Nagai N,Kudo Y,Kawamoto T,Kato Y,Hiyama E,Hiyama K,Nishiyama M

    更新日期:2007-04-01 00:00:00

  • Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.

    abstract::Cervical cancer is the second most common gynecological malignancy. The mechanisms of the genesis and progression of cervical cancer are complicated and not thoroughly understood. DEK is reported as an oncogene in various cancers, such as acute myeloid leukemia, bladder cancer, breast cancer and hepatocellular cancer....

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5721

    authors: Xu X,Zou L,Yao Q,Zhang Y,Gan L,Tang L

    更新日期:2017-08-01 00:00:00

  • Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.

    abstract::Breast cancer metastasizes to the bone in a majority of patients with advanced disease resulting in bone destruction. The underlying mechanisms are complex, and both processes are controlled by an interaction between locally and systemically derived signals. Clinically, breast cancer patients with depression have a hi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4430

    authors: Zong JC,Wang X,Zhou X,Wang C,Chen L,Yin LJ,He BC,Deng ZL

    更新日期:2016-02-01 00:00:00

  • Role of 4‑aminobutyrate aminotransferase (ABAT) and the lncRNA co‑expression network in the development of myelodysplastic syndrome.

    abstract::IncRNAs play an important role in the regulation of gene expression. The present study profiled differentially expressed lncRNAs (DELs) and mRNAs (DEMs) in myelodysplastic syndrome (MDS) to construct a 4‑aminobutyrate aminotransferase (ABAT)‑DEL‑DEM co‑expression network in MDS development using the Agilent human Bead...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7175

    authors: Chen Y,Zhao G,Li N,Luo Z,Wang X,Gu J

    更新日期:2019-08-01 00:00:00

  • Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA‑485‑5p/CKS1B axis.

    abstract::Colorectal cancer (CRC) is a common malignancy globally. The aim of the present study was to explore the role and the working mechanism of circular RNA NADPH oxidase 4 (circNOX4; circBase ID, hsa_circ_0023990) in CRC. Reverse transcription‑quantitative (RT‑q)PCR was used to examine the expression of circNOX4, NOX4 mRN...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7758

    authors: Wang X,Tao G,Huang D,Liang S,Zheng D

    更新日期:2020-11-01 00:00:00

  • Deferoxamine inhibits TRAIL-mediated apoptosis via regulation of autophagy in human colon cancer cells.

    abstract::Deferoxamine (DFO), an iron chelator, has numerous clinical applications for patients presenting with iron overload in regards to the improvement in the quality of life and overall survival. In addition, experimental iron chelators have demonstrated potent anticancer properties. The present study investigated the effe...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3676

    authors: Moon JH,Jeong JK,Park SY

    更新日期:2015-03-01 00:00:00

  • Advanced non-seminomatous germ cell cancer of the testis with brain metastases: feasibility of additional brain irradiation and whole body hyperthermia plus chemotherapy.

    abstract::Patients with brain metastases in disseminated non-seminomatous germ cell cancer of the testis are treated by combined modality, e.g., cisplatin-containing chemotherapy, whole brain irradiation and/or surgical excision. However, cure rates of patients refractory to that standard treatment are low (5-year survival rate...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.2.219

    authors: Feyerabend T,Wiedemann GJ,Steeves R

    更新日期:2001-03-01 00:00:00

  • High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities.

    abstract::Human papillomavirus (HPV) L1 capsid protein is only produced during a productive HPV infection at the end of the natural viral life cycle and is a major target of the immune response in women with HPV-related squamous intraepithelial lesions. We evaluated the usefulness of L1 detection by immunocytochemistry in high-...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2538

    authors: Norman I,Hjerpe A,Andersson S

    更新日期:2013-08-01 00:00:00

  • Cetuximab-mediated ADCC activity is correlated with the cell surface expression level of EGFR but not with the KRAS/BRAF mutational status in colorectal cancer.

    abstract::Cetuximab, an IgG1 monoclonal antibody against the epidermal growth factor receptor (EGFR), is widely used for the treatment of metastatic colorectal cancer (mCRC). One of the mechanisms of action is considered to be antibody-dependent cell-mediated cytotoxicity (ADCC) triggered by Fcγ-R on natural killer cells. Howev...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3077

    authors: Seo Y,Ishii Y,Ochiai H,Fukuda K,Akimoto S,Hayashida T,Okabayashi K,Tsuruta M,Hasegawa H,Kitagawa Y

    更新日期:2014-05-01 00:00:00

  • Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats.

    abstract::The identification of the specific molecular targets, which underlie liver carcinogenesis is essential for the establishment of an effective strategy for the prevention and/or treatment of hepatocellular carcinomas (HCCs). We previously found that a malfunction of RXRalpha due to its aberrant phosphorylation was assoc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Ando N,Shimizu M,Okuno M,Matsushima-Nishiwaki R,Tsurumi H,Tanaka T,Moriwaki H

    更新日期:2007-10-01 00:00:00

  • Ku80 gene knockdown by the CRISPR/Cas9 technique affects the biological functions of human thyroid carcinoma cells.

    abstract::In the present study, to evaluate the role of Ku80 in thyroid carcinoma (TC), 86 thyroid tissue samples from patients with a spectrum of thyroid disorders were examined for protein levels of Ku80, nuclear factor‑κB (NF‑κB) and RET/TC by immunohistochemistry. Furthermore, in TC cells, Ku80 mRNA was detected by reverse ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7348

    authors: Fan Y,Li J,Wei W,Fang H,Duan Y,Li N,Zhang Y,Yu J,Wang J

    更新日期:2019-12-01 00:00:00

  • Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro.

    abstract::Pancreatic cancer is one of the most lethal cancers, with an incidence equaling mortality. It is a heterogeneous group of neoplasms in which pancreatic ductal adenocarcinoma is most common. Pancreatic cancer cannot be cured even if detected early. When treatment is initiated, a suit...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2020

    authors: Takata T,Ishigaki Y,Shimasaki T,Tsuchida H,Motoo Y,Hayashi A,Tomosugi N

    更新日期:2012-12-01 00:00:00

  • The hTERT protein as a marker for malignancy in meningiomas.

    abstract::The meningioma evolution remains problematic as 6 to 19% relapse after total resection. We have no criterion or marker to predict with certainty the tumour behaviour, and the WHO grading system is to a certain degree controversial. Telomerase expression seems to play an active role in conferring to the tumour cell ind...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kalala JP,Maes L,Vandenbroecke C,de Ridder L

    更新日期:2005-02-01 00:00:00

  • Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.

    abstract::Hereditary multiple exostoses (HME) is an autosomal dominant bone disorder characterized by the presence of multiple benign cartilage-capped tumors. EXT1 located on chromosome 8q23-q24 and EXT2 located on 11p11-p12 are the main disease-causing genes which are responsible for ~90% of HME cases. Mutations of EXT1 or EXT...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2891

    authors: Cao L,Liu F,Kong M,Fang Y,Gu H,Chen Y,Zhao C,Zhang S,Bi Q

    更新日期:2014-02-01 00:00:00

  • Hepatitis B virus X protein sensitizes HL-7702 cells to oxidative stress-induced apoptosis through modulation of the mitochondrial permeability transition pore.

    abstract::Chronic hepatitis B virus (HBV) infection is a leading cause of liver cirrhosis and cancer. Among the pathogenic factors of HBV, HBV X protein (HBx) is attracting increased attention. Although it is documented that HBx is a multifunctional regulator that modulates cell inflammation and apoptosis, the exact mechanism r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5225

    authors: Gao WY,Li D,Cai DE,Huang XY,Zheng BY,Huang YH,Chen ZX,Wang XZ

    更新日期:2017-01-01 00:00:00

  • Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.

    abstract::Improvements in detection, treatment and prognosis for patients with non-small cell lung cancer (NSCLC) depend on the molecular understanding of tumor development and progression. Using Affymetrix GeneChips comprising 59,620 elements, we determined the gene expression profiles of 89 NSCLC and 15 normal lung samples. W...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Hofmann HS,Bartling B,Simm A,Murray R,Aziz N,Hansen G,Silber RE,Burdach S

    更新日期:2006-09-01 00:00:00

  • Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.

    abstract::During the last decade, microRNAs (miRNAs) have been identified as potential biomarkers and therapeutic targets for multiple malignancies; yet, few studies exist on intrahepatic cholangiocarcinoma (ICC). In the present study, a miRNA microarray was applied to determine the significant miRNAs involved in ICC. miR-150 w...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3641

    authors: Wang S,Yin J,Li T,Yuan L,Wang D,He J,Du X,Lu J

    更新日期:2015-02-01 00:00:00

  • GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system.

    abstract::Prostate cancer (PCa) growth initially depends on circulating androgens. Gonadotropin-releasing hormone (GnRH) agonists are currently used for the treatment of PCa. However, after an initial responsiveness to hormonal deprivation, PCa progresses and metastasizes. Recently, also GnRH antagonists have been used for clin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.15.2.393

    authors: Dondi D,Festuccia C,Piccolella M,Bologna M,Motta M

    更新日期:2006-02-01 00:00:00

  • Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.

    abstract::B-cell-specific Moloney murine leukemia virus insertion site 1 (Bmi1) is directly involved in cell growth, proliferation and self-renewal of cancer stem cells (CSCs). The aim of the present study was to assess the role of Bmi1 in the maintenance of stemness properties and tumorigenicity of human bladder CSC-like side ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2919

    authors: Zhu D,Wan X,Huang H,Chen X,Liang W,Zhao F,Lin T,Han J,Xie W

    更新日期:2014-02-01 00:00:00

  • Fetal fibronectin: a new screening-marker for bladder cancer?

    abstract::Early detection of transitional cell carcinoma (TCC) of the urinary bladder is essential for effective treatment. While several serum markers have been evaluated, none have been widely accepted for practical clinical use. Thus, urinary markers have been introduced and investigated to detect the evidence of bladder can...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.3.669

    authors: Wunderlich H,Reichelt O,Zermann DH,Schubert J,Berndt A,Kosmehl H

    更新日期:2001-05-01 00:00:00

  • Apoptosis induced by PGC-1β in breast cancer cells is mediated by the mTOR pathway.

    abstract::The peroxisome proliferator-activated receptor-γ (PPAR-γ) coactivator-1β (PGC-1β) is a well-established regulator of mitochondrial biogenesis. However, the underlying mechanism of PGC-1β action remains elusive. This study reveals that knockdown of endogenous PGC-1β by short-hairpin RNA (shRNA) leads to a decrease in t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2628

    authors: Wang L,Liu Q,Li F,Qiu J,Fan H,Ma H,Zhu Y,Wu L,Han X,Yang Z,Jiang H,Wei J,Xia H

    更新日期:2013-10-01 00:00:00

  • Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.

    abstract::Chronic stress and a high-fat diet are well-documented risk factors associated with the renin-angiotensin system in the development of breast cancer. The angiotensin II type 1 receptor (AT1R) is a novel component of the renin-angiotensin system. Several recent studies have focused on the function of AT1R in cell proli...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1720

    authors: Du N,Feng J,Hu LJ,Sun X,Sun HB,Zhao Y,Yang YP,Ren H

    更新日期:2012-06-01 00:00:00

  • MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.

    abstract::MicroRNAs (miRNAs) that negatively regulate gene expression play a key role in the development and progression of cancer. Aberrant expression of hsa-miR-187 (miR-187) has been reported in various malignancies. However, the function of miR-187 in tumor progression remains controversial and its role in non-small cell lu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5548

    authors: Cai Y,Ruan J,Yao X,Zhao L,Wang B

    更新日期:2017-05-01 00:00:00

  • Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.

    abstract::Inhibins are dimeric glycoproteins, composed of an α-subunit and one of two possible β-subunits (βA or βB), with substantial roles in human reproduction and in endocrine-responsive tumours. Recently a novel β subunit named βC was described, although it is still unclear if normal or cancerous cervical epithelial cells ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Blankenstein T,Jückstock J,Shabani N,Kunze S,Brüning A,Bergauer F,Mylonas I

    更新日期:2011-01-01 00:00:00

  • CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.

    abstract::CD44 has diverse functions in cell-cell and cell-matrix interactions and may be a determinant of metastatic and invasive behaviour in carcinomas. CD44 variant 6 (CD44v6) has been postulated to be involved in both carcinogenesis and tumor progression. Therefore, we have examined CD44v6 expression in tumors from 57 pati...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.11.1.41

    authors: Bendardaf R,Lamlum H,Ristamäki R,Pyrhönen S

    更新日期:2004-01-01 00:00:00